Drug Type Small molecule drug |
Synonyms Cortisol 21-phosphate, Hydrocortisone 21-phosphate, Hydrocortisone sodium phosphate (JP17/USP) + [3] |
Target |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (08 Jun 1960), |
Regulation- |
Molecular FormulaC21H31Na2O8P |
InChIKeyKKFIZYONMZSRGA-OJJGEMKLSA-N |
CAS Registry6000-74-4 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Shock | JP | 20 Jan 1975 |
Not Applicable | Dry Eye Syndromes meibomian gland disfunction (MGD) | - | cxvkidhaqg(mduguvyynv) = eswttsyctl bnxzpneknu (ozdgsqvxfq ) View more | Positive | 23 Apr 2023 | ||
Sodium Hyaluronate and Trehalose Eye drops | cxvkidhaqg(mduguvyynv) = rafybzodlp bnxzpneknu (ozdgsqvxfq ) View more |